ViVita Technologies, Inc.
  • Company
  • Science
  • Team
  • Background
  • Applications
  • News
  • FCOI
  • Contact
  • Company
  • Science
  • Team
  • Background
  • Applications
  • News
  • FCOI
  • Contact
Search by typing & pressing enter

YOUR CART

Biomaterials Enabling Regenerative Medicine

ViVita's patented platform technology—the SPEAR Process—removes the immunological barriers from animal-derived tissues. The resultant biomaterial—the BARE Patch—is immune-compatible for use in human patients and provides the body a blueprint for regeneration. Leveraging this technology, ViVita aims to generate off-the-shelf tissue and organ replacements that avoid long-term medication, repeat transplants, and associated patient deaths. 
Picture

Our Vision

​ViVita is at the forefront of the emerging tissue engineering and regenerative medicine market. ViVita aims to apply our novel, patented technology—the SPEAR Platform—to produce a spectrum of xenogeneic extracellular matrix (ECM)-based tissue and organ replacement products. ​

Our Mission

​ ViVita's mission is to address the unmet clinical need for replacement tissues and organs by providing off-the-shelf, animal-derived biomaterial products. ViVita's immune-compatible, regenerative products become the patient's own tissues following implantation, thereby providing patients a life-long cure.

ViVita Technologies, Inc. 2018